H5N1 influenza vaccine (monovalent) - formulation 1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for H5N1 influenza vaccine (monovalent) - formulation 1, covering 2015-10-12 to 2015-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects [Phase 2]